Specify a stock or a cryptocurrency in the search bar to get a summary
Dishman Carbogen Amcis Limited
DCALDishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP. Address: Dishman Corporate House, Ahmedabad, India, 380058
Analytics
WallStreet Target Price
13 931.49 INRP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DCAL
Dividend Analytics DCAL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
2 %Dividend History DCAL
Stock Valuation DCAL
Financials DCAL
Results | 2019 | Dynamics |